Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance

Go back to Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2020 Financial Results; Introduces Fiscal Year 2021 Guidance
(NASDAQ: ORGO) Delayed: 2.42 -0.01 (0.41%)
Previous Close $2.43    52 Week High
Open $2.42    52 Week Low
Day High $2.45    P/E N/A 
Day Low $2.32    EPS
Volume 363,538